Of mice and men: Sparse statistical modeling in cardiovascular genomics
暂无分享,去创建一个
Pascal J. Goldschmidt-Clermont | Mike West | David M. Seo | M. West | P. Goldschmidt-Clermont | D. Seo
[1] K. Possinger,et al. Increased expression of the tetraspanins CD53 and CD63 on apoptotic human neutrophils , 2000, Journal of leukocyte biology.
[2] J. Pedersen-Lane,et al. Analysis of the thiol status of peripheral blood leukocytes in rheumatoid arthritis patients , 2007, Journal of leukocyte biology.
[3] P. Müller,et al. A Bayesian mixture model for differential gene expression , 2005 .
[4] M. West,et al. Gene expression phenotypic models that predict the activity of oncogenic pathways , 2003, Nature Genetics.
[5] F. Ohsuzu,et al. The effect of interleukin-1 receptor antagonist on arteries and cholesterol metabolism. , 2006, Journal of atherosclerosis and thrombosis.
[6] L. Wasserman,et al. Operating characteristics and extensions of the false discovery rate procedure , 2002 .
[7] R. Spang,et al. Predicting the clinical status of human breast cancer by using gene expression profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] M. Clyde,et al. Model Uncertainty , 2003 .
[9] J F Cornhill,et al. Topographic Study of Sudanophilic Lesions in Cholesterol‐Fed Minipigs by Image Analysis , 1985, Arteriosclerosis.
[10] A. Raz. On the Role of Galectin-3 in Cancer Metastasis : From the Bench to the Clinic and Back , 2008 .
[11] C. Devlin,et al. Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[12] R. Mahley,et al. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.
[13] H. Hamm,et al. Thrombin Modulates the Expression of a Set of Genes Including Thrombospondin-1 in Human Microvascular Endothelial Cells* , 2005, Journal of Biological Chemistry.
[14] K. Nath,et al. Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties. , 1998, Kidney international.
[15] Matthew West,et al. Bayesian factor regression models in the''large p , 2003 .
[16] M. West,et al. High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics , 2008, Journal of the American Statistical Association.
[17] J. S. Rao,et al. Spike and Slab Gene Selection for Multigroup Microarray Data , 2005 .
[18] Zhigang Zhou,et al. TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. , 2007, Cellular signalling.
[19] S. Fazio,et al. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation , 1995, Science.
[20] Carlos M. Carvalho,et al. Sparse Statistical Modelling in Gene Expression Genomics , 2006 .
[21] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[22] M. West,et al. Gene expression profiling and genetic markers in glioblastoma survival. , 2005, Cancer research.
[23] J. S. Rao,et al. Detecting Differentially Expressed Genes in Microarrays Using Bayesian Model Selection , 2003 .
[24] P. Delafontaine,et al. Differential effects of low density lipoproteins on insulin-like growth factor-1 (IGF-1) and IGF-1 receptor expression in vascular smooth muscle cells. , 2000, The Journal of biological chemistry.
[25] James T. Wu,et al. Advanced glycosylation end products: A new disease marker for diabetes and aging , 1993, Journal of clinical laboratory analysis.
[26] A. Bayés‐Genís,et al. Effects of insulin-like growth factor-I on cultured human coronary artery smooth muscle cells. , 2003, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[27] M. West,et al. Gene expression predictors of breast cancer outcomes , 2003, The Lancet.
[28] Mike West,et al. Distinctions in the specificity of E2F function revealed by gene expression signatures. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[29] Rainer Spang,et al. DNA Microarray Data Analysis and Regression Modeling for Genetic Expression Profiling , 2000 .
[30] D. Kaul. Molecular link between cholesterol, cytokines and atherosclerosis , 2001, Molecular and Cellular Biochemistry.
[31] M. West,et al. Gene Expression Phenotypes of Oncogenic Signaling Pathways , 2003, Cell cycle.
[32] D. Madigan,et al. Bayesian Model Averaging for Linear Regression Models , 1997 .
[33] M. Boes,et al. Insulin, insulin-like growth factors, and vascular endothelium. , 1988, The American journal of medicine.
[34] G. Norata,et al. Oxidized Lipoproteins and Endothelium , 2000, Clinical chemistry and laboratory medicine.
[35] In Gyu Kim,et al. LPS-induced CD53 expression: a protection mechanism against oxidative and radiation stress. , 2004, Molecules and cells.
[36] T. Speed,et al. Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.
[37] M. West,et al. Molecular evidence for arterial repair in atherosclerosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Cybulsky,et al. Adhesion of Monocytes to Arterial Endothelium and Initiation of Atherosclerosis Are Critically Dependent on Vascular Cell Adhesion Molecule-1 Gene Dosage , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[39] M. West,et al. Distinct gene expression phenotypes of cells lacking Rb and Rb family members. , 2003, Cancer research.
[40] James G. Scott,et al. An exploration of aspects of Bayesian multiple testing , 2006 .
[41] J F Cornhill,et al. Topography of human aortic sudanophilic lesions. , 1990, Monographs on atherosclerosis.
[42] M. West,et al. Gene Expression Phenotypes of Atherosclerosis , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[43] L. Fabbri,et al. Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke. , 2006, American journal of respiratory and critical care medicine.
[44] M. West,et al. Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[45] Y. Shen,et al. p53-dependent apoptosis pathways. , 2001, Advances in cancer research.
[46] D. Green,et al. Mechanisms of p53-dependent apoptosis. , 2001, Biochemical Society transactions.
[47] E. George,et al. Journal of the American Statistical Association is currently published by American Statistical Association. , 2007 .
[48] G. Romeo,et al. Role of galectin-3 as a receptor for advanced glycosylation end products. , 2000, Kidney international. Supplement.
[49] S. Menini,et al. Development of age-dependent glomerular lesions in galectin-3/AGE-receptor-3 knockout mice. , 2005, American journal of physiology. Renal physiology.
[50] Jeffrey T. Chang,et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.
[51] Sylvia Richardson,et al. Bayesian Hierarchical Model for Identifying Changes in Gene Expression from Microarray Experiments , 2002, J. Comput. Biol..
[52] G. Pugliese,et al. Role of galectin-3 in diabetic nephropathy. , 2003, Journal of the American Society of Nephrology : JASN.
[53] P. Wilson,et al. Monocyte cytokine production in an elderly population: effect of age and inflammation. , 1998, The journals of gerontology. Series A, Biological sciences and medical sciences.
[54] S. Schwartz,et al. Osteopontin Expression in Cardiovascular Diseases a , 1995, Annals of the New York Academy of Sciences.